106 related articles for article (PubMed ID: 9685898)
1. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver.
Ogawara K; Nishikawa M; Takakura Y; Hashida M
J Control Release; 1998 Jan; 50(1-3):309-17. PubMed ID: 9685898
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M
J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383
[TBL] [Abstract][Full Text] [Related]
3. Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.
Nishida K; Eguchi Y; Takino T; Takakura Y; Hashida M; Sezaki H
Pharm Res; 1991 Oct; 8(10):1253-7. PubMed ID: 1796043
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.
Nishikawa M; Miyazaki C; Yamashita F; Takakura Y; Hashida M
Am J Physiol; 1995 May; 268(5 Pt 1):G849-56. PubMed ID: 7762669
[TBL] [Abstract][Full Text] [Related]
5. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
[TBL] [Abstract][Full Text] [Related]
6. Liver uptake and hepato-biliary transfer of galactosylated proteins in rats are determined by the extent of galactosylation.
Staud F; Nishikawa M; Takakura Y; Hashida M
Biochim Biophys Acta; 1999 Apr; 1427(2):183-92. PubMed ID: 10216235
[TBL] [Abstract][Full Text] [Related]
7. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver.
Nishida K; Mihara K; Takino T; Nakane S; Takakura Y; Hashida M; Sezaki H
Pharm Res; 1991 Apr; 8(4):437-44. PubMed ID: 1714579
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.
Opanasopit P; Nishikawa M; Yamashita F; Takakura Y; Hashida M
J Drug Target; 2001; 9(5):341-51. PubMed ID: 11770704
[TBL] [Abstract][Full Text] [Related]
9. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells.
Higuchi Y; Nishikawa M; Kawakami S; Yamashita F; Hashida M
Int J Pharm; 2004 Dec; 287(1-2):147-54. PubMed ID: 15541921
[TBL] [Abstract][Full Text] [Related]
10. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
11. Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver.
Deal KA; Cristel ME; Welch MJ
Nucl Med Biol; 1998 May; 25(4):379-85. PubMed ID: 9639300
[TBL] [Abstract][Full Text] [Related]
12. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.
Fumoto S; Nakadori F; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2003 Sep; 20(9):1452-9. PubMed ID: 14567641
[TBL] [Abstract][Full Text] [Related]
13. Hepatic local disposition of a drug with high protein binding and high hepatic clearance using BOF-4272 as a model drug.
Nishimura M; Yamaoka K; Naito S; Nakagawa T
Biol Pharm Bull; 1996 Sep; 19(9):1197-202. PubMed ID: 8889040
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of biodistribution data obtained with radiolabeled proteins in mice.
Nishikawa M; Staud F; Takemura S; Takakura Y; Hashida M
Biol Pharm Bull; 1999 Feb; 22(2):214-8. PubMed ID: 10077446
[TBL] [Abstract][Full Text] [Related]
15. Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.
Nishikawa M; Hirabayashi H; Takakura Y; Hashida M
Pharm Res; 1995 Feb; 12(2):209-14. PubMed ID: 7784335
[TBL] [Abstract][Full Text] [Related]
16. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system.
Yoshida M; Mahato RI; Kawabata K; Takakura Y; Hashida M
Pharm Res; 1996 Apr; 13(4):599-603. PubMed ID: 8710753
[TBL] [Abstract][Full Text] [Related]
17. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.
Hirabayashi H; Nishikawa M; Takakura Y; Hashida M
Pharm Res; 1996 Jun; 13(6):880-4. PubMed ID: 8792426
[TBL] [Abstract][Full Text] [Related]
18. Oleate uptake kinetics in the perfused rat liver are consistent with pseudofacilitation by albumin.
Sorrentino D; Van Ness K; Stump D; Berk PD
J Hepatol; 1994 Oct; 21(4):551-9. PubMed ID: 7814801
[TBL] [Abstract][Full Text] [Related]
19. Control of in vivo fate of albumin derivatives utilizing combined chemical modification.
Fujita T; Nishikawa M; Ohtsubo Y; Ohno J; Takakura Y; Sezaki H; Hashida M
J Drug Target; 1994; 2(2):157-65. PubMed ID: 8069594
[TBL] [Abstract][Full Text] [Related]
20. Hepatic disposition characteristics of recombinant human interleukin-11 (rhIL-11) in the perfused rat liver.
Takagi A; Yabe Y; Yoshida M; Takakura Y; Hashida M
Biol Pharm Bull; 1998 Dec; 21(12):1364-6. PubMed ID: 9881656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
